How often does tigecycline cause liver problems?
Liver-related side effects with tigecycline are uncommon overall, but they are a known risk. In clinical trial and prescribing-information reporting, the most frequently observed liver findings are lab abnormalities such as elevated liver enzymes (for example, ALT/AST), rather than clinically obvious hepatitis.
What kinds of “liver issues” have been reported?
When people ask about “liver issues” with tigecycline, they usually mean one of these:
- Elevated liver enzymes on blood tests (transaminases), sometimes with increased bilirubin.
- Less commonly, clinically apparent liver injury (hepatitis) presenting with symptoms like jaundice, fatigue, or abdominal discomfort.
Does the risk depend on how patients are treated?
Liver abnormalities are more likely to be noticed in patients who already have risk factors or liver abnormalities at baseline, and risk can rise with longer exposure. Severity ranges from mild, reversible enzyme elevations to more serious events, which is why clinicians monitor liver tests during therapy.
What symptoms should patients watch for?
Patients (and caregivers) are typically advised to report signs that could suggest liver injury, such as:
- Yellowing of the skin or eyes (jaundice)
- Dark urine or pale stools
- Persistent nausea, vomiting, marked fatigue
- Right upper abdominal pain
If liver enzymes rise during treatment, what usually happens?
In practice, clinicians may:
- Continue therapy with closer monitoring for mild enzyme increases.
- Hold or stop tigecycline if liver injury is suspected or if lab abnormalities become significant or accompanied by symptoms.
Sources
No prescribing-information or trial table data (with exact incidence percentages for ALT/AST elevations or hepatitis) was included in the information provided here. If you share the specific tigecycline product label or the trial/section you’re using (or the patient population), I can pinpoint the exact reported rates for that document.